Zogenix Reports Positive Top-Line Results From Relday(TM) Phase 1b Multi-Dose Clinical Trial
September 30, 2015 at 08:01 AM EDT
Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, ...
